TG Therapeutics News

TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance

Nov 4 20:24

TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.2%)

Oct 8 05:11

TG Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 10 04:12

TG Therapeutics | 10-K/A: Annual report (Amendment)

Aug 10 04:03

TG Therapeutics | 8-K: ® TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance

Aug 6 19:13

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar

Jun 21 06:12

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HUME DANIEL

Jun 21 06:12

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hoberman Kenneth

Jun 21 06:07

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann

Jun 21 06:07

TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N

Jun 21 06:07

TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 21 05:08

TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 21 03:57

TG Therapeutics | 8-K: Current report

Jun 18 04:51

TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 18 03:10

TG Therapeutics | PX14A6G: Notice of exempt solicitation

Jun 14 03:15

TG Therapeutics | PX14A6G: Notice of exempt solicitation

Jun 10 23:28

TG Therapeutics | 10-Q: Q1 2024 Earnings Report

May 7 05:00

TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

May 1 19:09

TG Therapeutics | ARS: Annual Report to Security Holders

Apr 30 05:08

TG Therapeutics | DEFA14A: Others

Apr 30 04:42